Breast Cancer Awareness Month is an annual campaign held in October to raise awareness about the prevalence of breast cancer and promote early detection, education, and support for individuals affected by this disease.
In recognition of this awareness month, Editors from across our hybrid and OA oncology journals have chosen the following articles to highlight the latest advances in breast cancer research.
- Cellular mechanisms underlying response and resistance to CDK4/6 inhibitors in the treatment of hormone receptor-positive breast cancer
- Artificial intelligence in mammographic phenotyping of breast cancer risk: a narrative review
- Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society
- KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway
- Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment
- Gene expression predicts dormant metastatic breast cancer cell phenotype
- Infertility and risk of breast cancer in men: a national case–control study in England and Wales
- Development and validation of an AI-enabled digital breast cancer assay to predict early-stage breast cancer recurrence within 6 years
- Breast cancer worry, uncertainty, and perceived risk following breast density notification in a longitudinal mammography screening cohort
Breast Cancer Research and Treatment
- A retrospective study in tumour characteristics and clinical outcomes of overweight and obese women with breast cancer
- Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells
- Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer
- Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system
- Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol
- Clinical trials of immunotherapy in triple-negative breast cancer